A homoharringtonine-based regimen for childhood acute myelogenous leukemia
โ Scribed by Tang, JingYan ;Xue, Huiliang ;Pan, Ci ;Chen, Jing ;Gu, LongJun ;Zhao, HuiJun
- Publisher
- John Wiley and Sons
- Year
- 2003
- Tongue
- English
- Weight
- 61 KB
- Volume
- 41
- Category
- Article
- ISSN
- 0098-1532
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Eighty-six consecutive untreated adults with acute myelogenous leukemia were treated with a combination of Adriamycin, vincristine, prednisolone, Cytosine Arabinoside, and BCG. Complete remission was achieved in 39 (45%) patients; these patients were then allocated on an alternate basis to receive B
## Abstract ## Background Homoharringtonine (HHT) is a plant alkaloid that is derived from a Chinese evergreen tree. Its mechanism of action is thought to be by inhibition of protein, DNA, and RNA synthesis by inhibition of chain initiation. The treatment of acute myelogenous leukemia (AML) in chi